- Home
- DLPN vs VYNE Comparison
DLPN vs VYNE Comparison
Compare DLPN & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLPN | VYNE |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 20.0M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DLPN | VYNE |
|---|---|---|
| Price | $1.61 | $0.61 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 204.6K |
| Earning Date | 03-25-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.81 | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $51,684,984.00 | N/A |
| Revenue This Year | $10.62 | N/A |
| Revenue Next Year | $13.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.85 | N/A |
| 52 Week Low | $0.75 | $0.29 |
| 52 Week High | $1.88 | $1.98 |
Technical Indicators
Market Signals| Indicator | DLPN | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 50.28 | 53.39 |
| Support Level | $1.51 | $0.56 |
| Resistance Level | $1.71 | $0.75 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 44.90 | 57.63 |
Price Performance
Historical ComparisonAbout DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.